 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
Printed on recycled paper128th MAINE LEGISLATURE
FIRST REGULAR SESSION-2017
Legislative Document No. 232
S.P. 78 In Senate,  January  24, 2017
An Act  To Establish an  Exemption to  the 30-day Supply Limitation 
on Certain Pain Medication
Reference to the Committee on Health  and Human Services suggested and  ordered printed.
HEATHER  J.R. PRIEST
Secretary of the Senate
Presented by Senator DAVIS of Piscataquis.
Cosponsored by Representative BLACK  of Wilton and
Senators: CYRWAY  of Kennebec, HAMPER of Oxford, MIRAMANT of Knox, 
Representative: TIMBERLAKE of Turner.

 
 Page 1 - 128LR0381(01) -1 
 Be it enacted by the People of the State of Maine as follows:  1 
Sec. 1.  32 MRSA §2210, sub -§1, ¶C, as enacted by PL 2015, c. 488, §13, is 2 
amended to read:  3 
C.  On or after January 1, 2017, within a 30 -day period, more than a 30 -day supply of 4 
an opioid medica tion to a patient under treatment for chronic pain or more than a 5 
6-month supply of an opioid medication to a patient under treatment for chronic pain 6 
who will be out of the country at the end of the 30 -day period .  "Chronic pain" has 7 
the same meaning as i n Title 22, section 7246, subsection 1 -C; or  8 
Sec. 2.  32 MRSA §2600 -C, sub -§1, ¶C, as enacted by PL 2015, c. 488, §17, is 9 
amended to read:  10 
C.  On or after January 1, 2017, within a 30 -day period, more than a 30 -day supply of 11 
an opioid medication to a patie nt under treatment for chronic pain or more than a 12 
6-month supply of an opioid medication to a patient under treatment for chronic pain 13 
who will be out of the country at the end of the 30 -day period .  For purposes of this 14 
paragraph, "chronic pain" has the same meaning as in Title 22, section 7246, 15 
subsection 1 -C; or  16 
Sec. 3.  32 MRSA §3300 -F, sub -§1, ¶C, as enacted by PL 2015, c. 488, §20, is 17 
amended to read:  18 
C.  On or after January 1, 2017, within a 30 -day period, more than a 30 -day supply of 19 
an opioid medi cation to a patient under treatment for chronic pain or more than a 20 
6-month supply of an opioid medication to a patient under treatment for chronic pain 21 
who will be out of the country at the end of the 30 -day period .  "Chronic pain" has 22 
the same meaning as  in Title 22, section 7246, subsection 1 -C; or  23 
Sec. 4.  32 MRSA §3657, sub -§1, ¶C, as enacted by PL 2015, c. 488, §23, is 24 
amended to read:  25 
C.  On or after January 1, 2017, within a 30 -day period, more than a 30 -day supply of 26 
an opioid medication to a patie nt under treatment for chronic pain or more than a 27 
6-month supply of an opioid medication to a patient under treatment for chronic pain 28 
who will be out of the country at the end of the 30 -day period .  "Chronic pain" has 29 
the same meaning as in Title 22, sec tion 7246, subsection 1 -C; or  30 
Sec. 5.  32 MRSA §18308, sub -§1, ¶C, as enacted by PL 2015, c. 488, §32, is 31 
amended to read:  32 
C.  On or after January 1, 2017, within a 30 -day period, more than a 30 -day supply of 33 
an opioid medication to a patient under treatme nt for chronic pain or more than a 34 
6-month supply of an opioid medication to a patient under treatment for chronic pain 35 
who will be out of the country at the end of the 30 -day period .  For purposes of this 36 
paragraph, "chronic pain" has the same meaning as in Title 22, section 7246, 37 
subsection 1 -C; or  38 
 
 Page 2 - 128LR0381(01) -1 
 SUMMARY  1 
Current law prohibits an individual licensed to prescribe opioid medication from 2 
prescribing more than a 30 -day supply of an opioid medication to a patient under 3 
treatment for chronic pain.  This bill a llows an individual licensed to prescribe opioid 4 
medication to prescribe no more than a 6 -month supply of an opioid medication to a 5 
patient under treatment for chronic pain who will be out of the country at the end of the 6 
30-day period.  7 
 
